Covered recipient · General Payments record
PRANATHI R MANDADI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,986.04
- Reported across 311 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $538.76 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $178.02 | 13 |
| Novo Nordisk AS | $152.06 | 10 |
| Amgen Inc. | $61.75 | 4 |
| Acerta Pharma LLC | $41.79 | 3 |
| Exact Sciences Corporation | $34.08 | 2 |
| PFIZER INC. | $30.50 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $26.53 | 1 |
| GlaxoSmithKline, LLC. | $14.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.75 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104952960 | CMS |
| ABBVIE INC. | $7.11 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104952964 | CMS |
| ABBVIE INC. | $7.31 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104952968 | CMS |
| ABBVIE INC. | $26.55 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104952972 | CMS |
| ABBVIE INC. | $5.01 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104952976 | CMS |
| ABBVIE INC. | $26.92 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104952979 | CMS |
| ABBVIE INC. | $16.23 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104952983 | CMS |
| ABBVIE INC. | $14.52 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104952987 | CMS |
| ABBVIE INC. | $13.80 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104952991 | CMS |
| ABBVIE INC. | $13.91 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104952995 | CMS |
| ABBVIE INC. | $2.90 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104952999 | CMS |
| ABBVIE INC. | $17.43 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104953003 | CMS |
| ABBVIE INC. | $13.58 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104953007 | CMS |
| Amgen Inc. | $15.44 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117618746 | CMS |
| Amgen Inc. | $16.13 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117618748 | CMS |
| Amgen Inc. | $16.61 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115898662 | CMS |
| Amgen Inc. | $13.57 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117618750 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.72 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105518125 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.45 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105892982 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.62 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104703825 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $26.53 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086245696 | CMS |
| Exact Sciences Corporation | $16.75 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114770536 | CMS |
| Exact Sciences Corporation | $17.33 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114770542 | CMS |
| GlaxoSmithKline, LLC. | $14.03 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116724108 | CMS |
| Novo Nordisk Inc | $23.92 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097272861 | CMS |
| Novo Nordisk Inc | $11.35 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096952929 | CMS |
| Novo Nordisk Inc | $19.03 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096715861 | CMS |
| Novo Nordisk Inc | $15.91 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097680759 | CMS |
| Novo Nordisk Inc | $12.63 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097774319 | CMS |
| Novo Nordisk Inc | $9.04 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096614182 | CMS |
| Novo Nordisk Inc | $12.41 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097133910 | CMS |
| Novo Nordisk Inc | $18.21 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096971477 | CMS |
| Novo Nordisk Inc | $14.77 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097595739 | CMS |
| Novo Nordisk Inc | $14.79 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097666261 | CMS |
| PFIZER INC. | $15.68 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131276051 | CMS |
| PFIZER INC. | $14.82 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132107844 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.